If you've been researching GLP-1 weight-loss injections, such as Mounjaro and Wegovy, you may have also heard talk of the body's "set point." But what is a set point? How does it influence long-term weight loss? And why do GLP-1 medications seem to work when traditional dieting often fails?
This evidence-based guide explains:
GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic the natural hormone GLP-1, which is released after eating. They help regulate appetite, control hunger signals in the brain, and improve metabolic functions.
Two widely prescribed options include:
Both are administered as once-weekly injections and have strong evidence supporting their effectiveness for weight loss and metabolic health.
The weight set point refers to the idea that each person's body has a preferred or biologically regulated weight range. When you lose weight rapidly or drastically through dieting, your body often activates compensatory mechanisms such as:
This makes weight re-gain common after dieting.
Why It Matters
Traditional dieting often fails because it does not alter the physiological drivers of weight regulation, like appetite and metabolic compensation.
Unlike calorie-focused diets alone, GLP-1 receptor agonists work on pathways that directly influence the neurological and metabolic drivers of appetite, effectively shifting the set point.
| 1 |
Appetite Regulation GLP-1 injections act directly in the brain's hunger and reward centres to reduce appetite and food reward drive. |
| 2 |
Slower Gastric Emptying Food stays in the stomach longer, enhancing fullness. |
| 3 |
Hormonal Balance They may reduce hunger signalling hormones and improve insulin sensitivity, making your body more receptive to sustained weight changes. |
This combination helps reset many of the biological drivers that worked against you during dieting.
The STEP programme - a series of large clinical trials published in journals like the New England Journal of Medicine, demonstrated:
Reference: Wilding JPH et al. 2021. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
Results from the SURMOUNT-1 trial showed:
Reference: Jastreboff AM et al. 2022. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM.
These findings suggest that GLP-1 (and dual-agonist) therapies impact the biological feedback loops that regulate appetite and weight, shifting the body's perceived set point rather than merely suppressing hunger short-term.
| Factor | Traditional Dieting | GLP-1 Medications |
|---|---|---|
| Appetite Regulation | Weak | Strong |
| Hunger Hormone Response | Increases | Decreases |
| Metabolic Compensation | High | Reduced |
| Long-Term Maintenance | Low | Higher with support |
| Clinical Evidence | Limited | Strong (STEP, SURMOUNT) |
You Will Regain All the Weight Once You Stop
Weight regain is possible if lifestyle support is not sustained, but GLP-1 medications can give you a window where appetite signals are normalised so that healthier habits take root.
GLP-1 Medications Are Just "Diet Pills"
These are medical therapies targeting underlying physiological drivers of obesity, not just calorie counting.
To make the most of GLP-1 therapies and support a healthier set point:
| ✔ | Work with a clinician to tailor dosing and monitoring |
| ✔ | Focus on protein intake and muscle-preserving exercise |
| ✔ | Address sleep, stress, and micronutrient status |
| ✔ | Combine medication with behavioural support |
Set point shift is strongest when medication and lifestyle changes are aligned.
Q: How long do GLP-1 injections take to work?
Appetite suppression can begin within weeks, with meaningful weight loss often seen within 3-6 months.
Q: Do you regain weight after stopping GLP-1 therapy?
Weight regain can occur unless lifestyle habits (nutrition, movement, behaviour) are maintained.
Q: Can GLP-1 injections change metabolism?
They don't "speed up" metabolism directly, but they reduce hunger hormones and improve insulin signalling.
Q: Who is eligible for GLP-1 weight-loss therapy?
Typically adults with BMI ≥30, or BMI ≥27 with weight-related conditions. Clinical guidelines vary by region.
Q: Is set point science proven?
Yes, decades of research support the concept of biological weight regulation (e.g., leptin and hypothalamic regulation), and GLP-1 meds interact with these pathways.
Bottom Line
GLP-1 weight-loss injections like Wegovy and Mounjaro go beyond simple appetite suppression. By targeting the neurological and hormonal mechanisms that govern hunger and weight regulation, they help overcome biological resistance, often described as the "set point."
To use them effectively:
| ✔ | Pair with evidence-based lifestyle support |
| ✔ | Get medical guidance throughout treatment |
| ✔ | Prioritise habits that reinforce long-term maintenance |
GLP-1 therapy doesn't just help you lose weight, it can help your body accept a new, healthier range over time.
Your Tribe Is Here
This is why our platform exists. We're building a bigger, stronger tribe for women, a space where you're seen, heard, and supported.
Whether you're navigating endometriosis, fertility struggles, or simply seeking better information, our mission is to empower you with resources, education, and community.
The journey to better women's health starts here. Let's close the gap together.
Stay connected with regular updates on our social platforms and newsletters.
Because every woman deserves healthcare that sees her, hears her, and heals her.